Insulin Resistance combi Analysis
A combined determination of insulin and glucose in blood for determining the HOMA 2 index
Insulin Resistance combi Analysis
The combined determination of insulin and glucose in the blood makes it possible to determine the so-called HOMA index; an indicator for the degree of Insulin Resistance. It is often difficult to have this determination carried out via the general practitioners, because they do not like to cooperate with this.
MEASUREMENT OF GLUCOSE IN BLOOD ONLY IS NOT ENOUGH
Early detection of insulin resistance
The advance of diabetes mellitus type 2 (DM2) is increasing strongly worldwide and that also applies to the Netherlands. With an unchanged policy, it is estimated that the number of people diagnosed with diabetes mellitus will increase from 740,000 in 2007 to 1.3 million in 2025. However, the onset of DM2 can be delayed or even prevented by lifestyle guidance in people at high risk for the disease. disease. For example, the Dutch Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM) found a decrease in the incidence of diabetes mellitus of almost 60% in participants who completed a 3-year lifestyle intervention.
The standard approach within regular medicine is not physiologically correct because in general GPs focus unilaterally on measuring glucose levels in the blood. However, an increase in insulin production can be observed as early as 10-20 years before a rise in blood glucose levels. Insulin resistance is the cause, and a rise in blood glucose levels years later is the result.
AN INCREASED CA/MG RATIO AND BMI ARE THE REASON FOR THE ANALYSIS
An analysis demonstrating different risks
An increased Ca/Mg ratio (Lifestyle ratio) and the sugar sensitivity in the Hair Mineral Analysis, but also your BMI, are reasons for us to have a series of blood values determined that determine the presence, extent and degree of insulin resistance and the consequences of it in terms of low-grade inflammation and cardiovascular disease risk. The combined determination of insulin, C-peptide and glucose in the blood makes it possible to determine the HOMA index. The HOMA index is an index that indicates the presence and degree of insulin resistance.
Insulin resistance is often accompanied by a systemic inflammatory activity that we call ‘low-grade inflammation’.
High-sensitive CRP is a good parameter to determine this.
Antibodies against oxidized LDL cholesterol are an important indicator of cardiovascular disease.
Homocysteinecis an important risk factor for insulin resistance, diabetes, cardiovascular disease, cancer, Alzheimer’s, susceptibility to hip fractures and various psychiatric disorders.
The results are displayed in easy-to-read overviews. This offers the therapist and the client great ease of use.
DOWNLOAD SAMPLE REPORT OF THE INSULIN RESISTANCE COMBI ANALYSIS
THE HOMA-2 index
The HOMA calculation was derived from RIA insulin and C-peptide in a UK population of 299 and 383 non-diabetic men and women with a mean age of approximately 50 years, using insulin and C-peptide assays developed at the university. of Oxford have been used between 1996 and 1998. The Oxford University computer model is used to determine insulin sensitivity (%S) and beta cell function (%B) based on paired fasting plasma glucose and RIA insulin, specific insulin or C- peptide concentrations over a range of 1–2,200 pmol/l for insulin and 1–25 mmol/l for glucose.
In case of a diagnosed Diabetes type II, we use the HOMA2 calculation with the glucose and the insulin value. In non-diabetics we use glucose and C-peptide.
A therapist will receive an extensive report and you will be trained by us in the interpretation.
A consumer receives a comprehensible report with a video explanation.
Simply order the Insulin Resistance combi Analysis
The Insulin Resistance combi Analysis can be ordered by therapists who, once registered with us, can order this analysis via our webshop. We take care of the contact with the lab, the client can have blood drawn via an injection clinic in his environment. The report is provided by us and prepared in the My Health platform or made available separately.
The Insulin Resistance combi analysis can also be ordered by consumers who are actively concerned with their health and vitality and are not being treated by a therapist. The report is written in a simple language.